Drug Channels Archive for July, 2026

Click a link below to view the mailing archive as if it had been sent to you.

2026-07-24 07:47		Drug Channels - Direct-to-Patient: Transforming the Manufacturer Access Model
2026-07-21 07:47		Drug Channels - 2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges
2026-07-17 07:47		Drug Channels - Direct-to-Consumer Shouldn't Always Mean Direct-To-Mail-Order: Why Fulfillment Choice Matters
2026-07-15 07:47		Drug Channels - The 340B Program Hit $100 Billion in 2025: Has It Become Too Big to Reform?
2026-07-14 07:47		Drug Channels - Medicare Embraces Site-Neutral Payments. Why Haven't Employers?
2026-07-10 07:47		Drug Channels - When Access Tightens, Prior Authorization Execution Becomes the Differentiator
2026-07-08 07:47		Drug Channels - The Hidden Cost of 340B for Employers and Health Plans